During the past decade, Bugát Pál Kórház, Bőrgyógyászati Szakrendelés conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bugát Pál Kórház, Bőrgyógyászati Szakrendelés" are "Atopic Dermatitis" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "Bugát Pál Kórház, Bőrgyógyászati Szakrendelés" in a lesser frequency.

Most popular intervention types in "Bugát Pál Kórház, Bőrgyógyászati Szakrendelés" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "PF-04965842" (1 trials) and "PF04965842" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bugát Pál Kórház, Bőrgyógyászati Szakrendelés" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bugát Pál Kórház, Bőrgyógyászati Szakrendelés". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Bugát Pál Kórház, Bőrgyógyászati Szakrendelés, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bugát Pál Kórház, Bőrgyógyászati Szakrendelés, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".